Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

AKRO

AKRO News

Newswire

10:14

Liver Fibrosis Market Growth Driven by Innovation from Key Players

04:26

Novo Nordisk Raises €3.5bn through Multi-Tranche Bond Sale to Fund Akero Acquisition

07:10

Akero Therapeutics Reports Efruxifermin's Antifibrotic Effects in Phase 2b Trials.

07:03

Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting.

16:43

Akero Therapeutics Investigation for Breach of Fiduciary Duties and Securities Law Violations

View More

About AKRO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More